| human | Q5 |
| P2798 | Loop ID | 456773 |
| P496 | ORCID iD | 0000-0002-1194-6614 |
| P1153 | Scopus author ID | 35094949500 |
| P69 | educated at | Klinikum der Johann Wolfgang Goethe-Universität Frankfurt | Q101268807 |
| University of Bonn | Q152171 | ||
| University Hospital Muenster | Q1748138 | ||
| P108 | employer | Ruhr University Bochum | Q309948 |
| University Hospital Muenster | Q1748138 | ||
| Knappschaftskrankenhaus Bochum-Langendreer | Q1776898 | ||
| Universitätsklinikum Frankfurt am Main | Q2496384 | ||
| P734 | family name | Bracht | Q21508592 |
| Bracht | Q21508592 | ||
| Bracht | Q21508592 | ||
| P106 | occupation | researcher | Q1650915 |
| Q43415554 | A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors |
| Q48206638 | An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma |
| Q39259431 | Analysis of U2 small nuclear RNA fragments in the bile differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders |
| Q41163686 | Analysis of disease-associated protein expression using quantitative proteomics—fibulin-5 is expressed in association with hepatic fibrosis. |
| Q36399787 | BioInfra.Prot: A comprehensive proteomics workflow including data standardization, protein inference, expression analysis and data publication. |
| Q91958724 | C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle |
| Q89840249 | CalibraCurve: A Tool for Calibration of Targeted MS-Based Measurements |
| Q39108916 | Comparison of label-free and label-based strategies for proteome analysis of hepatoma cell lines. |
| Q59350694 | Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients |
| Q37707024 | Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC. |
| Q37064540 | Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients |
| Q40034662 | Hepatic expression of proteasome subunit alpha type-6 is upregulated during viral hepatitis and putatively regulates the expression of ISG15 ubiquitin-like modifier, a proviral host gene in hepatitis C virus infection. |
| Q34303381 | Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma. |
| Q36745088 | Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected Cells |
| Q91630639 | Integrated Fourier Transform Infrared Imaging and Proteomics for Identification of a Candidate Histochemical Biomarker in Bladder Cancer |
| Q84579209 | Monoclonal antibodies reveal the alteration of the rhodocetin structure upon α2β1 integrin binding |
| Q38785494 | One Sample, One Shot - Evaluation of sample preparation protocols for the mass spectrometric proteome analysis of human bile fluid without extensive fractionation. |
| Q57273249 | Proteome Analysis of a Hepatocyte-Specific BIRC5 (Survivin)-Knockout Mouse Model during Liver Regeneration |
| Q34609315 | Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study. |
| Q41993861 | Quantitative Analysis of Proteome Modulations in Alveolar Epithelial Type II Cells in Response to Pulmonary Aspergillus fumigatus Infection |
| Q38386901 | Quantitative Secretome Analysis of Activated Jurkat Cells Using Click Chemistry-Based Enrichment of Secreted Glycoproteins |
| Q40253359 | Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma |
| Q38375370 | Quantitative proteome analysis of plasma microparticles for the characterization of HCV-induced hepatic cirrhosis and hepatocellular carcinoma. |
| Q51574758 | Quantitative proteome analysis reveals the correlation between endocytosis-associated proteins and hepatocellular carcinoma dedifferentiation. |
| Q30843287 | Spatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and proteomics |
| Q117886127 | Structural mechanism of CRL4‐instructed STAT2 degradation via a novel cytomegaloviral DCAF receptor |
| Q91786957 | Systematic Comparison of Label-Free, SILAC, and TMT Techniques to Study Early Adaption toward Inhibition of EGFR Signaling in the Colorectal Cancer Cell Line DiFi |
| Q27654821 | The alpha2beta1 integrin-specific antagonist rhodocetin is a cruciform, heterotetrameric molecule |
| Q51610744 | Tissue-based quantitative proteome analysis of human hepatocellular carcinoma using tandem mass tags. |
Search more.